The hospital acquired disease testing refers to clinical procedures, which are used to detect infection that patients are contracted while staying in the hospital, such as MRSA, C. difficile, sepsis, and ventilator-associated pneumonia. The market testing for the market is increasing due to increasing incidence of infections associated with healthcare, increased antimicrobial resistance, and rapid, to prevent outbreaks and improve patient results. Additionally, progress in point-of-care tests, molecular diagnosis and transition control protocols is accelerating adoption in healthcare facilities worldwide.
Key Growth Drivers and Opportunities
Increasing Incidence of Infections Associated with Healthcare: Increasing incidence of healthcare infections-as M MRSA, C. difficile, and ventilator-associated pneumonia is a major driver, a major driver, which is the test market. These infections not only increase the cost of patient sickness and health care, but also demand more accurate clinical solutions to enable timely intervention and control. As hospitals strive to meet strict transition control rules and improve the patient’s results, the need to be reliable continues to increase testing technologies, promoting market expansion.
Challenges
Hospital acquired disease (HAD) tests faces several borders, including high costs associated with advanced molecular diagnosis, limited availability of rapid point-care solutions in resource-settings, and capacity for false positive or negative due to sample contamination or sample contamination or low pathogen load. Additionally, in traditional laboratory-based methods, test results may obstruct clinical decisions on time. The lack of standardized testing protocols in institutions and complicate the increasing risk of antimicrobial resistance and complicate more accurate diagnosis and treatment, faced challenges for effective infection controls.
Innovation and Expansion
Hospital-Acquired Infection Monitoring is Being Transformed by Decentralized Diagnostics
In November 2024, The Azienda Ospedaliero-Universitaria Careggi hospital and Don Gnocchi, a rehabilitation facility in Florence, Italy, have teamed together to establish an infection prevention and control approach. The Don Gnocchi Foundation spearheaded their efforts by installing a Cepheid GeneXpert technology for screening carbapenemase-producing enterobacterales (CPE) on-site.
Microbiologists from the Azienda Ospedaliero-Universitaria di Careggi then remotely and in real time confirm the results improved infection prevention and control, improved patient care, and total cost savings for the Don Gnocchi Foundation are all made possible by this methodology.
Southern Ohio Medical Center Uses MEDITECH Expanse to Reduce C. difficile Rates by 30%
In August 2022, Hospital-acquired C. difficile infections have decreased by 30% and test cancellations have decreased by 32% at Southern Ohio Medical Center (Portsmouth, OH). These outstanding accomplishments were the result of MEDITECH Professional Services (MPS) and SOMC’s Quality Improvement Team working together to enhance patient outcomes, increase evidence-based treatment, and expedite the time-consuming, ineffective testing procedures.
As part of its ongoing efforts to maintain high quality metrics on a publicly published measure, SOMC demonstrated a 30% relative decrease in hospital-acquired C. difficile. This helped the company avoid fines based on value-based payment models and boost customer confidence. By improving antibiotic prescribing procedures, this program has also aided their antimicrobial stewardship initiatives.
Inventive Sparks, Expanding Markets
Major development strategies for hospital acquired disease testing companies include rapid point-off-care and multiplex test platforms, strategic partnerships with hospitals and public health agencies, investing in AI-powered clinical equipment, regular approval for new assays and targeting emerging markets with scalable, low-cost solutions.
About Author:
Prophecy is a specialized market research, analytics, marketing and business strategy, and solutions company that offer strategic and tactical support to clients for making well-informed business decisions and to identify and achieve high value opportunities in the target business area. Also, we help our client to address business challenges and provide best possible solutions to overcome them and transform their business.
